Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines.
- Published in:
- 2011
- By:
- Publication type:
- Report
Works matching IS 01676997 AND DT 2011 AND VI 29 AND IP 2
Results: 28
1
2
Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/ß-catenin pathway.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
3
Cellular pharmacology of multi- and duplex drugsconsisting of ethynylcytidine and 5-fluoro-2'-deoxyuridine.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
4
Lupane Triterpenoids---Betulin and Betulinic acid derivatives induce apoptosis in tumor cells.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
5
Anti-tumor activity and mechanisms of a novel vascular disrupting agent, (Z)-3,4',5-trimethoxylstilbene-3'-O-phosphate disodium (M410)
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
6
A phase I study of pemetrexed in patients with relapsed or refractory acute leukemia.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 323, doi. 10.1007/s10637-009-9369-7
- By:
- Publication type:
- Article
7
A phase I study of S-1 treatment with a 3 week schedule in advanced biliary cancer patients with or without hepatic dysfunction.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 332, doi. 10.1007/s10637-009-9378-6
- By:
- Publication type:
- Article
8
Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/ β-catenin pathway.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 273, doi. 10.1007/s10637-009-9359-9
- By:
- Publication type:
- Article
9
Phase II trial of pyrazoloacridine (NSC#366140) in patients with metastatic breast cancer.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 347, doi. 10.1007/s10637-009-9338-1
- By:
- Publication type:
- Article
10
Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 207, doi. 10.1007/s10637-009-9342-5
- By:
- Publication type:
- Article
11
CYT997 Causes apoptosis in human multiple myeloma.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 232, doi. 10.1007/s10637-009-9350-5
- By:
- Publication type:
- Article
12
Inhibitory effects of tea polyphenols by targeting cyclooxygenase-2 through regulation of nuclear factor kappa B, Akt and p53 in rat mammary tumors.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 225, doi. 10.1007/s10637-009-9349-y
- By:
- Publication type:
- Article
13
Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 352, doi. 10.1007/s10637-009-9348-z
- By:
- Publication type:
- Article
14
Oleanolic acid derivative Dex-OA has potent anti-tumor and anti-metastatic activity on osteosarcoma cells in vitro and in vivo.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 258, doi. 10.1007/s10637-009-9354-1
- By:
- Publication type:
- Article
15
Phase II study of vinorelbine monotherapy in anthracycline and taxane pre-treated metastatic breast cancer.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 360, doi. 10.1007/s10637-009-9357-y
- By:
- Publication type:
- Article
16
Selective proapoptotic activity of polyphenols from red wine on teratocarcinoma cell, a model of cancer stem-like cell.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 239, doi. 10.1007/s10637-009-9352-3
- By:
- Publication type:
- Article
17
Cellular pharmacology of multi- and duplex drugsconsisting of ethynylcytidine and 5-fluoro-2′-deoxyuridine.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 248, doi. 10.1007/s10637-009-9353-2
- By:
- Publication type:
- Article
18
Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma.
- Published in:
- 2011
- By:
- Publication type:
- Report
19
Lupane Triterpenoids-Betulin and Betulinic acid derivatives induce apoptosis in tumor cells.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 266, doi. 10.1007/s10637-009-9358-x
- By:
- Publication type:
- Article
20
Antitumor effect of BPR-DC-2, a novel synthetic cyclic cyanoguanidine derivative, involving the inhibition of MDR-1 expression and down-regulation of p-AKT and PARP-1 in lung cancer.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 195, doi. 10.1007/s10637-009-9337-2
- By:
- Publication type:
- Article
21
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 366, doi. 10.1007/s10637-009-9363-0
- By:
- Publication type:
- Article
22
Temporal evolution of patient characteristics enrolled on phase I trials.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 312, doi. 10.1007/s10637-009-9362-1
- By:
- Publication type:
- Article
23
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 316, doi. 10.1007/s10637-009-9364-z
- By:
- Publication type:
- Article
24
A phase II study of everolimus in combination with imatinib for previously treated advanced renal carcinoma.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 374, doi. 10.1007/s10637-009-9365-y
- By:
- Publication type:
- Article
25
Anti-tumor activity and mechanisms of a novel vascular disrupting agent, (Z)-3,4′,5-trimethoxylstilbene-3′-O-phosphate disodium (M410).
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 300, doi. 10.1007/s10637-009-9366-x
- By:
- Publication type:
- Article
26
Dibutyltin(IV) complexes containing arylazobenzoate ligands: chemistry, in vitro cytotoxic effects on human tumor cell lines and mode of interaction with some enzymes.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 285, doi. 10.1007/s10637-009-9360-3
- By:
- Publication type:
- Article
27
Sphingosine-1-phosphate: a potential therapeutic agent against human breast cancer.
- Published in:
- 2011
- By:
- Publication type:
- Report
28
A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 340, doi. 10.1007/s10637-009-9383-9
- By:
- Publication type:
- Article